Welcome to our dedicated page for AMEREN SEC filings (Ticker: AEE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on AMEREN's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into AMEREN's regulatory disclosures and financial reporting.
Ameren Corporation (AEE) is conducting a registered offering of junior subordinated notes due March 15, 2057, as a takedown from its existing shelf registration. The notes are unsecured junior subordinated obligations that rank below all existing and future Senior Indebtedness and equally with any future Pari Passu Securities.
The notes pay fixed interest until March 15, 2032, then reset every five years to the Five-Year Treasury Rate plus a spread, with a floor equal to the initial fixed rate, and interest is paid semi-annually on March 15 and September 15, beginning March 15, 2027. Ameren may defer interest for up to 10 consecutive years per Optional Deferral Period, during which deferred interest compounds and certain dividend and junior debt payments are restricted.
Ameren may redeem the notes at par around the first reset date and on later interest payment dates, and also upon a Tax Deductibility Event (at 100%), a Rating Agency Event (at 102%), or a Tax Credit Event tied to "specified foreign entities" (at 101%, each plus accrued interest). Net proceeds are expected to be used for general corporate purposes, including repayment of commercial paper and other short-term debt.
AMEREN CORP (AEE) reported that Ryan J. Martin, SVP Finance, sold a total of 971 shares of common stock in open-market transactions, consisting of 500 shares at $109.88 on August 20, 2026 and 471 shares at $109.87 on August 18, 2026, all held directly. The filing also reports an indirect holding of 1,837 share equivalents in a unitized stock fund within the Ameren Corporation Savings Investment Plan as of July 31, 2026, and notes that reported amounts include 87 dividend equivalents accrued under restricted stock units granted pursuant to Ameren’s 2022 Omnibus Incentive Compensation Plan.
AMEREN CORP executive Theresa A. Shaw, SVP and CATO, reported selling 325 shares of common stock on August 14, 2026 at $108.93 per share in an open-market or private transaction pursuant to a Rule 10b5-1 trading plan. After this sale, she directly held 32,340 shares, which include 47 dividend equivalents accrued under restricted stock units. She also indirectly held 928 share equivalents through a unitized stock fund in the Ameren Corporation Savings Investment Plan as of July 31, 2026.
Ameren Corp Group President, Utilities Michael L. Moehn sold 6,500 shares of common stock on August 3, 2026 at $108.96 per share in an open-market transaction under a Rule 10b5-1 trading plan. After this sale, he directly holds 199,689 shares, including 590 dividend equivalents credited on restricted stock units, and indirectly holds an estimated 5,304 share equivalents through the Ameren Corporation Savings Investment Plan’s unitized stock fund as of July 31, 2026.
Ameren Corporation expanded its existing equity distribution program for its common stock. On July 31, 2026, the company delivered a notice under Section 3(x) of its Equity Distribution Sales Agreement with multiple financial institutions acting as sales agents, forward sellers and forward purchasers, increasing by $2,000,000,000 the aggregate gross sales price authorized under the program.
After this increase, Ameren states that common stock with an aggregate gross sales price of up to $2,266,700,000 remains available for issuance under the equity distribution program. The company is not obligated to offer or sell any common stock under the Sales Agreement and may suspend offers at any time.
Ameren Corporation is offering shares of its common stock in an "at the market" program and related forward sale arrangements for up to $2,266,700,000 of aggregate gross sales price. This is the remaining capacity under a previously authorized $5,000,000,000 sales agreement, of which $2,733,300,000 has already been sold.
Sales may be made through multiple major banks acting as sales agents, forward sellers and forward purchasers, including Barclays, BofA Securities, Goldman Sachs, J.P. Morgan, Mizuho, Morgan Stanley, MUFG, RBC and Wells Fargo. Ameren may also enter into forward sale agreements under which a forward purchaser or affiliate borrows and sells shares to hedge its position, with Ameren settling later in cash, shares or both.
Ameren intends to use any net proceeds it receives from direct share issuances or from settlement of forward sale agreements for general corporate purposes, which may include repayment of short‑term debt such as commercial paper. The company highlights that physical or net share settlement of forward sales will dilute earnings per share and return on equity, and that certain events could accelerate settlement or terminate forward contracts without proceeds.
A shareholder associated with AEE filed a notice of planned sales of 6,500 shares of common stock through Fidelity Brokerage Services LLC on the NYSE, with an indicated aggregate value of $708,240.00 as of 08/03/2026.
The shares were originally acquired from the issuer as restricted stock vesting compensation on multiple dates between 2019 and 2021, including 6,430 shares vested on 03/02/2020 and smaller vestings on 09/30/2019, 09/30/2020, 03/31/2021, 06/30/2021, and 09/30/2021.
Ameren Corporation reported higher second quarter 2026 results, with net income attributable to common shareholders of $314 million, or $1.13 diluted EPS, compared to $275 million, or $1.01, a year earlier. For the six months ended June 30, 2026, net income attributable to common shareholders was $671 million, or $2.41 diluted EPS, up from $564 million, or $2.08, in 2025.
Management attributes the year-over-year earnings increase primarily to returns on infrastructure investments that enhance reliability, resiliency and service quality, and to investments in innovative energy technology, partly offset by higher operations and maintenance expenses, lower electric retail sales due to milder weather, and higher interest expense. Segment results show Ameren Missouri earnings of $157 million, Ameren Transmission $96 million, Ameren Illinois Electric Distribution $70 million, Ameren Illinois Natural Gas $9 million, and a parent loss of $18 million in the quarter.
Ameren generated $1.191 billion in operating cash flow in the first half of 2026 and invested $2.653 billion in capital expenditures, funded in part by $1.794 billion of long-term debt issuance. Total assets were $51.216 billion and long-term debt $19.064 billion at June 30, 2026. The company reaffirmed its 2026 earnings guidance of $5.25 to $5.45 per diluted share, outlining numerous regulatory, operational, economic, and weather-related factors that could affect results.
Smith Patrick E reported acquisition or exercise transactions in this Form 4 filing.
Ameren Corp executive Patrick E. Smith reported a stock award and updated holdings. He received a grant of 280 shares of Ameren common stock at no cost, bringing his direct ownership to 20,275 shares. He also reported indirect holdings of 968 shares held by his spouse and 3,113 share equivalents in a 401(k) plan.
Footnotes explain that part of his position consists of restricted stock units granted under Ameren’s 2022 Omnibus Incentive Compensation Plan, scheduled to vest with a payment date in 2029, no later than March 15, 2029. The filing also notes 84 dividend equivalents accrued on these units during the first half of 2026.
AMEREN CORP executive Aaron P. Melda, Chairman & President of a subsidiary, reported an acquisition of 2,520 shares of common stock at a price of $0.00 per share as a grant or award. These restricted stock units were granted under Ameren's 2022 Omnibus Incentive Compensation Plan and are scheduled to vest on a payment date in 2029, which will be no later than March 15, 2029, subject to the plan and award terms. Following this grant and related accrued dividend equivalents, Melda’s directly reported holdings increased to 6,251 shares, while an estimated 4 share equivalents are held indirectly in a unitized stock fund within the Ameren Corporation Savings Investment Plan.